CATS Oct 2019 17.500 call

OPR - OPR Delayed Price. Currency in USD
0.2000
0.0000 (0.00%)
As of 1:21PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.2000
Open0.2000
Bid0.0000
Ask0.2500
Strike17.50
Expire Date2019-10-18
Day's Range0.5000 - 0.5200
Contract RangeN/A
Volume7
Open Interest116
  • Business Wire

    Catasys Announces $45 Million Debt Financing Commitment from Goldman Sachs to Support Accelerating Growth

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, has entered into a financing agreement with Goldman Sachs Specialty Lending Group, L.P. (“Goldman Sachs”) involving the placement of Senior Secured Notes due 2024 pursuant to a committed purchase of up to $45 million, comprised of a $35 million initial purchase and up to $10 million in additional issuances. Catasys intends to use the proceeds to retire the Company’s existing credit facilities, continue scaling new contracts and expansions, invest in additional technology enhancements, develop new products including the Catasys PRE™ platform, and provide excess capital for growth. Mr. Terren Peizer, Chairman and CEO of Catasys, stated, “We are pleased to have closed this financing with Goldman Sachs in support of our growth initiatives without significant dilution to shareholders.

  • Thomson Reuters StreetEvents

    Edited Transcript of CATS earnings conference call or presentation 14-Aug-19 8:30pm GMT

    Q2 2019 Catasys Inc Earnings Call

  • Catasys (NASDAQ:CATS) Is Making Moderate Use Of Debt
    Simply Wall St.

    Catasys (NASDAQ:CATS) Is Making Moderate Use Of Debt

    Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

  • CATASYS INC (CATS) Q2 2019 Earnings Call Transcript
    Motley Fool

    CATASYS INC (CATS) Q2 2019 Earnings Call Transcript

    CATS earnings call for the period ending June 30, 2019.

  • Benzinga

    Q2 Earnings Preview For Catasys

    On Wednesday, August 14, Catasys (NASDAQ: CATS ) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Earnings and Revenue Sell-side analysts are expecting Catasys's ...

  • GlobeNewswire

    BriaCell Appoints Richard J. Berman to Board of Directors

    BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage.

  • Analysts Estimate Catasys (CATS) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Catasys (CATS) to Report a Decline in Earnings: What to Look Out for

    Catasys (CATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • MoneyShow

    Catasys CATS- 2019 Top Picks' Mid-Year Update

    Nate Pile, editor of Nate's Notes, selected Catasys (CATS) as his top investment idea for 2019. The stock has since risen 105%. Here's his latest update on the health services provider.

  • Catasys (NASDAQ:CATS) Shareholders Have Enjoyed A Whopping 339% Share Price Gain
    Simply Wall St.

    Catasys (NASDAQ:CATS) Shareholders Have Enjoyed A Whopping 339% Share Price Gain

    Investing can be hard but the potential fo an individual stock to pay off big time inspires us. Not every pick can be...

  • Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales
    Business Wire

    Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced the appointment of Daniel Prewitt as the senior vice president of sales.

  • GlobeNewswire

    Sharon R. Gabrielson Named Chair of Sharps Compliance Board of Directors

    Sharon Gabrielson joined the Sharps Compliance board in February 2019.  She is a progressive healthcare executive with over 30 years of broad-based leadership experience in the healthcare industry and currently serves as Chair of Global Business Solutions for the Mayo Clinic, where she is responsible for directing domestic and international business development opportunities for the Clinic’s healthcare products and services to the B2B and B2C markets.  Previously, Ms. Gabrielson was Vice Chair of Mayo’s Health System Administration, where she oversaw an organization of community-based practices including hospitals, clinics, nursing homes, and home health, which generated approximately $2 billion in revenues. Ms. Gabrielson has served on numerous leadership and management committees at Mayo Clinic, as well as industry boards including for-profit public and private, as well as not-for-profit and community organizations.

  • Thomson Reuters StreetEvents

    Edited Transcript of CATS earnings conference call or presentation 9-May-19 8:30pm GMT

    Q1 2019 Catasys Inc Earnings Call

  • Business Wire

    Catasys Adds Canary Health to OnTrak Platform

    Partnership Expands Online Support for Members with Chronic Disease

  • InvestorPlace

    7 Stocks to Buy That Are Near 52-Week Highs

    When markets have large selloffs and are making new lows, I always like to check out the list of stocks that are making new highs. I do this to find new investment opportunities because I believe that if these stocks perform well in bad markets, they will probably do even better when the markets eventually turn around and are rising.Don't let the "fake news" financial media scare you with their gloom and doom reporting. There is always a bull market somewhere! Coda Octopus Group, Inc. (NASDAQ:CODA) is first one my list. Besides having a really cool name, they make really cool products. This company is in the 3D sonar business.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIt is considered a defense company because they sell a lot of their products to the military. There is no doubt that they are developing some top secret technology for the Navy. Over the past year it is up about 375% and traded at a new all-time new high this month.Biosig Technologies Inc. (NASDAQ:BSGM) also traded at an all-time high this month. The company makes medical devices that improve electrocardiograms. This company actually losses money.It lost about $17 million last year and about $13 million in the year before. I actually looked at the financials going back to 2014 and they have lost money every year since then.Despite the losses some investors clearly think that they will have more profitable prospects in the future. The price of the stock has doubled in price since November and made a new high in May.Catasys Inc. (NASDAQ:CATS) has also lost money every year since 2014 but investors don't seem to care. They must believe that the future prospects for profitability outweigh the current actual losses.Over the past year it has appreciated by about 140%. This company provides data analytics to the healthcare industry and this could explain the reason for the optimism.Data analytics and healthcare are two of the fasting growing industry and Catasys is involved in both of them.Everbridge Inc. (NASDAQ:EVBG) develops software for critical event management. In other words, if something bad happens to a company's computer infrastructure, such as being hacked, their product helps companies deal with it.This company also losses money. In 2016 it lost 68 cents per share, in 2017 it lost 70 cents per share and last year the losses were significantly worse at $1.63 per share.It appears to be headed in the wrong direction but investors don't seem to care. The stock price has appreciated by about 60% over the past year.GW Pharmaceuticals PLC (NASDAQ:GWPH) is a biotechnology company that develops products for the medical marijuana markets. This company is widely followed by Wall Street and has significant institutional investors backing it.Yesterday, Oppenheimer upgraded it to an "outperform" rating and they raised their target price from $191 to $227. The prices of the shares are up about 80% since November and it traded at an all-time high in May.Rent-A-Center Inc. (NASDAQ:RCII) rents things like furniture, electronics, appliances, computers and smartphones. They have retail stores throughout the country.The company has faced some controversy over the years because they charge very high interest rates and their customers are typically lower income earners. Investors apparently do not have an issue with this. The stock price has risen about %160 over the past year.Zynex Inc. (NASDAQ:ZYXI) designs, manufactures, and markets medical devices. They are considered by some to be the market leader in electrotherapy pain management.This type of treatment is an alternative to opioids. Maybe this could help to end the terrible opioid epidemic that is happening across the country.The market capitalization is only $223 million so it would be considered by most to be a small cap or microcap company. Only two Wall Street firms follow this company and they each have buy ratings on it. The price of the company's stock has doubled since August.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Stocks to Sell Before They Tank Your Portfolio * Top 7 Dow Jones Stocks of 2019 -- So Far * 5 Low-Priced, High-Potential Tech Stocks to Buy Compare Brokers The post 7 Stocks to Buy That Are Near 52-Week Highs appeared first on InvestorPlace.

  • Business Wire

    Catasys to Present at the B. Riley FBR Institutional Investor Conference on Wednesday, May 22, 2019

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and Chief Executive Officer, will present at the B.

  • Business Wire

    Catasys to Provide OnTrak™ Program Free to Members in Need Throughout May to Honor Mental Health Awareness Month

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that for every day in the month of May, it is sponsoring a health plan member who would otherwise not be able to participate in OnTrak, at no cost to either the member or the health plan.

  • Business Wire

    Catasys Reports 2019 First Quarter Financial Results

    LOS ANGELES-- -- Q1 2019 Record Revenue of $6.8 Million, Up 256% Year over Year and Up 21% from Q4 2018 Outreach Pool of Eligible Members Increases to Approximately 92,000 in May 2019, up 124% from 41,000 at December 31, 2018 Company Reiterates 2019 GAAP Revenue Guidance of $35 Million Company to Host Conference Call at 4:30 pm ET today Catasys, Inc. , a leading AI and technology-enabled healthcare ...